SI3100725T1 - Sredstvo, ki vsebuje derivate alkilnega etra ali sol le-tega, ki izboljšuje učinek rehabilizacije po poškodbi živčevja - Google Patents
Sredstvo, ki vsebuje derivate alkilnega etra ali sol le-tega, ki izboljšuje učinek rehabilizacije po poškodbi živčevjaInfo
- Publication number
- SI3100725T1 SI3100725T1 SI201531278T SI201531278T SI3100725T1 SI 3100725 T1 SI3100725 T1 SI 3100725T1 SI 201531278 T SI201531278 T SI 201531278T SI 201531278 T SI201531278 T SI 201531278T SI 3100725 T1 SI3100725 T1 SI 3100725T1
- Authority
- SI
- Slovenia
- Prior art keywords
- salt
- alkyl ether
- enhancing agent
- nerve injury
- ether derivative
- Prior art date
Links
- 208000028389 Nerve injury Diseases 0.000 title 1
- 150000005215 alkyl ethers Chemical class 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 230000008764 nerve damage Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014017587 | 2014-01-31 | ||
| PCT/JP2015/052617 WO2015115582A1 (ja) | 2014-01-31 | 2015-01-30 | アルキルエーテル誘導体またはその塩を含有する神経損傷後のリハビリテーション効果促進剤 |
| EP15743367.3A EP3100725B1 (en) | 2014-01-31 | 2015-01-30 | Post nerve injury rehabilitation effect-enhancing agent comprising an alkyl ether derivative or a salt thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3100725T1 true SI3100725T1 (sl) | 2020-08-31 |
Family
ID=53757150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201531278T SI3100725T1 (sl) | 2014-01-31 | 2015-01-30 | Sredstvo, ki vsebuje derivate alkilnega etra ali sol le-tega, ki izboljšuje učinek rehabilizacije po poškodbi živčevja |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US10039744B2 (sl) |
| EP (1) | EP3100725B1 (sl) |
| JP (3) | JP5837726B1 (sl) |
| KR (1) | KR102346219B1 (sl) |
| CN (1) | CN106061478B (sl) |
| AU (1) | AU2015211753B2 (sl) |
| BR (1) | BR112016017747A2 (sl) |
| CA (1) | CA2938184C (sl) |
| CY (1) | CY1123154T1 (sl) |
| DK (1) | DK3100725T3 (sl) |
| ES (1) | ES2792950T3 (sl) |
| HK (1) | HK1226298A1 (sl) |
| HR (1) | HRP20200796T1 (sl) |
| HU (1) | HUE050400T2 (sl) |
| IL (1) | IL246925B (sl) |
| LT (1) | LT3100725T (sl) |
| MX (1) | MX2016009751A (sl) |
| MY (1) | MY179290A (sl) |
| PH (1) | PH12016501507A1 (sl) |
| PL (1) | PL3100725T3 (sl) |
| PT (1) | PT3100725T (sl) |
| RS (1) | RS60462B1 (sl) |
| RU (1) | RU2680247C2 (sl) |
| SG (2) | SG11201606173TA (sl) |
| SI (1) | SI3100725T1 (sl) |
| WO (1) | WO2015115582A1 (sl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3100725T (pt) * | 2014-01-31 | 2020-06-17 | Fujifilm Toyama Chemical Co Ltd | Agente de melhoria do efeito de reabilitação após uma lesão de um nervo, compreendendo um derivado de éter de alquilo ou um seu sal |
| KR20180097581A (ko) * | 2015-12-25 | 2018-08-31 | 토야마 케미칼 컴퍼니 리미티드 | 1-(3-(2-(1-벤조티오펜-5-일)에톡시)프로필)아제티딘-3-올 또는 그 염을 포함하는 정제 |
| JP7057287B2 (ja) * | 2016-12-28 | 2022-04-19 | 富士フイルム富山化学株式会社 | 医薬組成物 |
| CN110139641B (zh) * | 2016-12-28 | 2022-09-09 | 富士胶片富山化学株式会社 | 外用组合物 |
| EP3563846B1 (en) * | 2016-12-28 | 2023-07-19 | FUJIFILM Toyama Chemical Co., Ltd. | Pharmaceutical composition and method for producing the same |
| US10849880B2 (en) | 2016-12-28 | 2020-12-01 | Fujifilm Toyama Chemical Co., Ltd. | Pharmaceutical composition |
| CN116492335A (zh) * | 2017-06-02 | 2023-07-28 | 富士胶片富山化学株式会社 | 脑萎缩预防或治疗剂 |
| MX2019014306A (es) | 2017-06-02 | 2022-06-09 | Fujifilm Toyama Chemical Co Ltd | Agente para reducir la cantidad de proteina beta amiloide. |
| AU2018277981B2 (en) * | 2017-06-02 | 2021-04-08 | Fujifilm Toyama Chemical Co., Ltd. | Agent for preventing or treating spinocerebellar ataxia |
| SG11201911520UA (en) * | 2017-06-02 | 2020-01-30 | Fujifilm Toyama Chemical Co Ltd | Agent for preventing or treating tauopathy |
| US11541033B2 (en) | 2017-06-02 | 2023-01-03 | Fujifilm Toyama Chemical Co., Ltd. | Agent for preventing or treating Alzheimer's disease |
| US11548878B2 (en) | 2017-10-30 | 2023-01-10 | Fujifilm Toyama Chemical Co., Ltd. | Emopamil binding protein binding agent and use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO122203B1 (ro) | 2001-10-19 | 2009-02-27 | Toyama Chemical Co., Ltd. | Derivaţi de alchil eter şi sărurile acestora |
| AU2002355033A1 (en) * | 2001-11-29 | 2003-06-10 | Japan Science And Technology Agency | Method of constructing spinal injury model monkey and utilization thereof |
| PT1514542E (pt) * | 2002-06-14 | 2012-03-27 | Toyama Chemical Co Ltd | Composição medicamentosa incluindo tacrina ou donepezilo para melhorar as funções cerebrais |
| SI1614419T1 (sl) * | 2003-04-17 | 2012-12-31 | Toyama Chemical Co., Ltd. | Preventivno sredstvo/zdravilo za bolezni vidnega ĺ˝ivca, vsebujoäśe derivate alkil etra ali soli le-teh |
| NZ561672A (en) | 2005-03-28 | 2010-04-30 | Toyama Chemical Co Ltd | Process for production of 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propyl)azetidin-3-ol or salts thereof |
| RU2397169C2 (ru) * | 2005-03-28 | 2010-08-20 | Тояма Кемикал Ко., Лтд. | Способ получения 1-(3-(2-(1-бензотиофен-5-ил)этокси) пропил)азетидин-3-ола или его солей |
| US8119625B2 (en) * | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| ZA200808728B (en) * | 2006-04-26 | 2010-01-27 | Toyama Chemical Co Ltd | Neurogenesis inducer or neuropathy Therapeutic agent comprising alkyl ether derivative or salt thereof |
| PT3100725T (pt) * | 2014-01-31 | 2020-06-17 | Fujifilm Toyama Chemical Co Ltd | Agente de melhoria do efeito de reabilitação após uma lesão de um nervo, compreendendo um derivado de éter de alquilo ou um seu sal |
-
2015
- 2015-01-30 PT PT157433673T patent/PT3100725T/pt unknown
- 2015-01-30 SG SG11201606173TA patent/SG11201606173TA/en unknown
- 2015-01-30 DK DK15743367.3T patent/DK3100725T3/da active
- 2015-01-30 CA CA2938184A patent/CA2938184C/en active Active
- 2015-01-30 RU RU2016135236A patent/RU2680247C2/ru active
- 2015-01-30 SG SG10201907035TA patent/SG10201907035TA/en unknown
- 2015-01-30 EP EP15743367.3A patent/EP3100725B1/en active Active
- 2015-01-30 KR KR1020167023717A patent/KR102346219B1/ko active IP Right Grant
- 2015-01-30 LT LTEP15743367.3T patent/LT3100725T/lt unknown
- 2015-01-30 JP JP2015539315A patent/JP5837726B1/ja active Active
- 2015-01-30 BR BR112016017747A patent/BR112016017747A2/pt not_active Application Discontinuation
- 2015-01-30 HU HUE15743367A patent/HUE050400T2/hu unknown
- 2015-01-30 SI SI201531278T patent/SI3100725T1/sl unknown
- 2015-01-30 RS RS20200754A patent/RS60462B1/sr unknown
- 2015-01-30 MY MYPI2016702668A patent/MY179290A/en unknown
- 2015-01-30 AU AU2015211753A patent/AU2015211753B2/en active Active
- 2015-01-30 PL PL15743367T patent/PL3100725T3/pl unknown
- 2015-01-30 US US15/115,416 patent/US10039744B2/en active Active
- 2015-01-30 ES ES15743367T patent/ES2792950T3/es active Active
- 2015-01-30 CN CN201580011450.3A patent/CN106061478B/zh active Active
- 2015-01-30 MX MX2016009751A patent/MX2016009751A/es active IP Right Grant
- 2015-01-30 WO PCT/JP2015/052617 patent/WO2015115582A1/ja active Application Filing
- 2015-11-04 JP JP2015216722A patent/JP6642914B2/ja active Active
-
2016
- 2016-07-25 IL IL24692516A patent/IL246925B/en active IP Right Grant
- 2016-07-29 PH PH12016501507A patent/PH12016501507A1/en unknown
- 2016-12-22 HK HK16114586A patent/HK1226298A1/zh unknown
-
2018
- 2018-06-12 US US16/005,774 patent/US10471044B2/en active Active
-
2019
- 2019-12-26 JP JP2019236541A patent/JP6825074B2/ja active Active
-
2020
- 2020-05-15 HR HRP20200796TT patent/HRP20200796T1/hr unknown
- 2020-07-23 CY CY20201100673T patent/CY1123154T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1226298A1 (zh) | 含有烷基醚衍生物或其鹽的神經損傷後的康復效果促進劑 | |
| GB201809461D0 (en) | Leg movement stimulator device | |
| ZA201607866B (en) | Solid-stabilized emulsion | |
| DK3233221T3 (da) | Træningsindretning | |
| IL249356B (en) | A derivative of 2-acylaminothiazole or its salt | |
| PL2918316T3 (pl) | Przyrząd do trenowania boksu | |
| HK1215689A1 (zh) | 面部肌肉鍛鍊器 | |
| PL3018257T3 (pl) | Słupek bariery | |
| GB201608979D0 (en) | Intraosseous infusion training system | |
| GB2526178B (en) | Horse-riding training device | |
| PL3085227T3 (pl) | Trenażer ruchu dla małych zwierząt | |
| GB2532578B (en) | Animal amusement device | |
| GB2522069B (en) | Bird guard device | |
| GB201405348D0 (en) | Training cassette for auto-injector | |
| GB201401108D0 (en) | A training device | |
| GB2524086B (en) | A deterrent device | |
| GB201402820D0 (en) | Fence attachment device | |
| ZA201705079B (en) | Deterrent device | |
| GB2546148B (en) | Animal deterrent | |
| GB201516639D0 (en) | Attachment for boxing training devices | |
| ES1144811Y (es) | Aparato de musculación | |
| GB201415801D0 (en) | Cat Fight Deterrent Colar | |
| GB201509604D0 (en) | Trainers etc | |
| UA31160S (uk) | Комбінезон для фітнесу | |
| HK1194600A2 (en) | Pets jacuzzi |